TY - JOUR
T1 - Neoadjuvant bleomycin, etoposide, and cisplatin in adult neuroblastoma arising from the broad ligament of the uterus
AU - Milam, Michael R.
AU - Gabel, Stephanie F.
AU - Milam, R. Ashley
AU - Liu, Jinsong
AU - Ramirez, Pedro T.
PY - 2007/11
Y1 - 2007/11
N2 - Background: A case of primary neuroblastoma arising from the broad ligament with excellent response to neoadjuvant bleomycin, etoposide, and cisplatin (BEP) is reported. Case: A 48-year-old woman, G0, who presented with acute renal failure, an enlarged pelvic mass, and abdominal pain was diagnosed with adult neuroblastoma arising from the broad ligament of the uterus. She received three cycles of neoadjuvant therapy consisting of bleomycin, etoposide, and cisplatin (BEP) given every 3 weeks and had an excellent initial response. She then underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and appendectomy, with pathologic analysis revealing small residual disease on the broad ligament of the uterus and omentum. The patient died of recurrent disease 20 months after her initial diagnosis. Conclusions: The clinical management of cancer in the broad ligament of the uterus must be tailored to the pathologic diagnosis. Although our patient had an excellent initial response to BEP, further study is needed to identify a treatment that can reduce recurrences and improve clinical outcomes.
AB - Background: A case of primary neuroblastoma arising from the broad ligament with excellent response to neoadjuvant bleomycin, etoposide, and cisplatin (BEP) is reported. Case: A 48-year-old woman, G0, who presented with acute renal failure, an enlarged pelvic mass, and abdominal pain was diagnosed with adult neuroblastoma arising from the broad ligament of the uterus. She received three cycles of neoadjuvant therapy consisting of bleomycin, etoposide, and cisplatin (BEP) given every 3 weeks and had an excellent initial response. She then underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and appendectomy, with pathologic analysis revealing small residual disease on the broad ligament of the uterus and omentum. The patient died of recurrent disease 20 months after her initial diagnosis. Conclusions: The clinical management of cancer in the broad ligament of the uterus must be tailored to the pathologic diagnosis. Although our patient had an excellent initial response to BEP, further study is needed to identify a treatment that can reduce recurrences and improve clinical outcomes.
KW - BEP
KW - Neoadjuvant chemotherapy
KW - Neuroblastoma
UR - http://www.scopus.com/inward/record.url?scp=35348826360&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35348826360&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2007.06.027
DO - 10.1016/j.ygyno.2007.06.027
M3 - Article
C2 - 17881040
AN - SCOPUS:35348826360
SN - 0090-8258
VL - 107
SP - 350
EP - 354
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 2
ER -